These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20619237)

  • 1. Digoxin therapy: A persisting interest despite contrary winds.
    Juillière Y; Selton-Suty C
    Arch Cardiovasc Dis; 2010 May; 103(5):281-4. PubMed ID: 20619237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on digoxin therapy in congestive heart failure.
    Haji SA; Movahed A
    Am Fam Physician; 2000 Jul; 62(2):409-16. PubMed ID: 10929703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug treatment of cardiac insufficiency with systolic dysfunction].
    Follath F
    Praxis (Bern 1994); 1997 Feb; 86(7):254-7. PubMed ID: 9139344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From digoxin to angiotensin-converting enzyme inhibitors: issues in pharmacotherapy for congestive heart failure.
    Hackenbruck HA
    Clin Excell Nurse Pract; 2000 Jul; 4(4):197-204. PubMed ID: 11261079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G; Sabbadini G; Zecchin M; Di Lenarda A
    G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic implications of treatment guidelines for congestive heart failure.
    Shibata MC; Nilsson C; Hervas-Malo M; Jacobs P; Tsuyuki RT
    Can J Cardiol; 2005 Dec; 21(14):1301-6. PubMed ID: 16341301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin use and digoxin toxicity in the post-DIG trial era.
    Hussain Z; Swindle J; Hauptman PJ
    J Card Fail; 2006 Jun; 12(5):343-6. PubMed ID: 16762795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of systolic heart failure in the elderly: an evidence-based review.
    Arif SA; Mergenhagen KA; Del Carpio RO; Ho C
    Ann Pharmacother; 2010 Oct; 44(10):1604-14. PubMed ID: 20841514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is digoxin effective in the treatment of heart insufficiency in patients with sinus rhythm?].
    Henriksen OM; Gadsbøll N
    Ugeskr Laeger; 1999 May; 161(22):3269-74. PubMed ID: 10485204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community management of heart failure.
    McKelvie RS
    Can Fam Physician; 1998 Dec; 44():2689-92, 2695-8. PubMed ID: 9870122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment guidelines for heart failure stress multidrug approach.
    Morey SS
    Am Fam Physician; 1999 Jun; 59(11):3265-6. PubMed ID: 10392599
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
    Gambassi G; Lapane KL; Sgadari A; Carbonin P; Gatsonis C; Lipsitz LA; Mor V; Bernabei R
    Arch Intern Med; 2000 Jan; 160(1):53-60. PubMed ID: 10632305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin therapy for heart failure: an update.
    Morris SA; Hatcher HF; Reddy DK
    Am Fam Physician; 2006 Aug; 74(4):613-8. PubMed ID: 16939183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Response to drug therapy of cardiac failure according to gender].
    Juillière Y; Berder V; Brembilla-Perrot B; Selton-Suty C
    Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1216-20. PubMed ID: 15669363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenging the dogma of high target doses in the treatment of heart failure: is more always better?
    Follath F
    Arch Cardiovasc Dis; 2009 Nov; 102(11):785-9. PubMed ID: 19944395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.